跳至主要内容
临床试验/NCT06489626
NCT06489626撤回4 期

The Effect of a Methylprednisolone Taper on Outcomes Following Total Knee Arthroplasty

F. Johannes Plate4 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
发起方
入组人数
100
试验地点
4
主要终点
Prescription narcotic usage

研究概览

简要总结

Pain control and early range of motion following total knee arthroplasty are essential for patient satisfaction. Intraoperative steroids (dexamethasone) have been shown to have a significant effect in controlling acute pain following total knee arthroplasty. This study aims to evaluate the effect of a post-operative steroid (methylprednisolone) taper in improving functional and patient-reported outcomes following total knee arthroplasty. A taper means taking a high dose of a medication followed by taking lower doses and each following day until the medication is stopped.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients indicated for primary total knee arthroplasty.
  • Access to computer or smartphone for completion of REDCap surveys

排除标准

  • Patients less than 18 years of age, patients unable to consent, known diabetic patients and those with an HgbA1c >6.5 preoperatively, patients who are on chronic steroid treatments, patients with chronic pain on opioid management, patients with allergies to steroids, patients with a history of peptic ulcer disease, patients with a history of heart failure and patients with a history of renal and/or hepatic failure will be excluded. Those that are immunosuppressed as well as pregnant and/or lactating will also be excluded.

研究组 & 干预措施

Intraoperative and Post-operative steroid

Experimental

Patients in this groups will receive intraoperative intravenous dexamethasone as well as a 6-day post-operative methylprednisolone taper

干预措施: Methylprednisolone 4 milligram Tab (Drug)

Intraoperative and Post-operative steroid

Experimental

Patients in this groups will receive intraoperative intravenous dexamethasone as well as a 6-day post-operative methylprednisolone taper

干预措施: Dexamethasone injection (Drug)

Intraoperative Steroid

Active Comparator

Patients randomized to this group will only receive intraoperative intravenous dexamethasone

干预措施: Dexamethasone injection (Drug)

结局指标

主要结局

Prescription narcotic usage

时间窗: daily for two weeks

Oral morphine equivalent units will be collected based on patient usage of prescribed narcotic pain medication

Daily Pain at rest and with movement

时间窗: daily for two weeks

numeric rating scale from 0 to 10 (0=minimal, 10=maximal) will be used to capture patient experienced pain

Sleep disturbance

时间窗: daily for two weeks

Patients will be asked if pain caused them to be awoken in the night and if so what level of pain they were experiencing at that time

Knee Range of motion

时间窗: 2-week, 6-week and 3-month postoperative visits

goniometric measurement of knee extension and flexion

次要结局

  • Wound healing(2-week, 6-week and 3-month postoperative visits)
  • Knee Injury and Osteoarthritis Outcome Scores(2-week, 6-week and 3-month postoperative visits)

研究者

发起方
F. Johannes Plate
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

F. Johannes Plate

Director of Research Division of Adult Reconstruction

University of Pittsburgh

研究点 (4)

Loading locations...

相似试验

The Effect of a Methylprednisolone Taper on Outcomes... | 临床试验